PharmaShots Weekly Snapshot (March 23-27, 2020)

1. Mylan Delays its Merger with Upjohn Due to COVID-19 Pandemic

Published: Mar 26, 2020 | Tags: Mylan, Delays, Merger, Upjohn, Due, COVID-19 Pandemic

2.  Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic2

Published: Mar 26, 2020 | Tags: Medopad, Provides, Remote Patient Monitoring Platform, Support, Global, COVID-19 Pandemic

3.  Quidel’s Lyra SARS-CoV-2 Assay Receives the US FDA’s Expanded Emergency Use Authorization for Molecular Detection of COVID-19

Published: Mar 26, 2020 | Tags: Quidel, Lyra SARS-CoV-2 Assay, Receives, US, FDA, Expanded, Emergency Use Authorization, Molecular Detection, COVID-19

4. Sanofi’s Sarclisa (isatuximab) Receives CHMP’s Positive Opinion for Relapsed and Refractory Multiple Myeloma

Published: Mar 27, 2020 | Tags: Sanofi, Sarclisa, isatuximab, Receives, CHMP, Positive Opinion, Relapsed, Refractory, Multiple Myeloma

5.  BMS’ Zeposia (ozanimod) Receives the US FDA’s Approval as New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Published: Mar 26, 2020 | Tags: BMS, Zeposia, ozanimod, Receives, US, FDA, Approval, New Oral Treatment, Relapsing Forms, Multiple Sclerosis

6. Boehringer Ingelheim Signs a Second Research Collaboration with Saniona to Develop Therapies Targeting Schizophrenia

Published: Mar 26, 2020 | Tags: Boehringer Ingelheim, Signs, Second, Research Collaboration, Saniona, Develop, Therapy, Targeting, Schizophrenia

7.  PRA Health Sciences Launches COVID-19 Monitoring App to Track Symptoms

Published: Mar 20, 2020 | Tags: PRA Health Sciences, Launches, COVID-19, Monitoring App, Track, Symptoms

8. Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19

Published: Mar 26, 2020 | Tags: Gates Foundation, Collaborates, Consortium of Life Sciences Companies, Addressing, Challenges, Against, COVID-19 Pandemic

9. AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) Receives MHLW’s Approval for the Treatment of Hyperkalemia in Japan

Published: Mar 26, 2020 | Tags: AstraZeneca, Lokelma, sodium zirconium cyclosilicate, Receives, MHLW, Approval, Treatment, Hyperkalemia, Japan

10. Vir Biotechnology Signs a License Agreement with Xencor to Utilize Xtend Fc Technology in Antibodies Targeting COVID-19

Published: Mar 25, 2020 | Tags: Vir Biotechnology, Signs, License Agreement, Xencor, Xtend Fc Technology, Antibodies, Targeting, COVID-19

11. Sorrento to Initiate the Novel Decoy Cellular Vaccine Program for COVID-19

Published: Mar 25, 2020 | Tags: Sorrento, Initiates, STI-6991, Novel, Decoy, Cellular Vaccine, Covid-19

12. AstraZeneca Collaborates with Silence Therapeutics to Develop siRNA Therapeutics Targeting Multiple Diseases

Published: Mar 25, 2020 | Tags: AstraZeneca, Collaborates, Silence Therapeutics, Develop, siRNA Therapeutics, Targeting, Multiple Diseases

13. Samsung Bioepis Receives the US FDA’s Approval for Multi-Dose Vial of Ontruzant (biosimilar, trastuzumab)

Published: Mar 24, 2020 | Tags: Samsung Bioepis, Receives, US, FDA, Approval, Multi-Dose Vial, Ontruzant, biosimilar, trastuzumab

14. Alvotech Signs an Exclusive License Agreement with DKSH for AVT02 (biosimilar, adalimumab) in Asia

Published:  Mar 24, 2020 | Tags: Alvotech, Signs, Exclusive, License Agreement, DKSH, AVT02, biosimilar, adalimumab, Asia

15. Merck KGaA’s Tepmetko (tepotinib) Receives the Japanese MHLW’s Approval for Advanced NSCLC with METex14 Skipping Alterations

Published: Mar 25, 2020 | Tags: Merck KGaA, Tepmetko, tepotinib, Receives, MHLW, Approval, Advanced, NSCLC, METex14 Skipping Alterations

16. Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia’s Apealea

Published: Mar 25, 2020 | Tags: Elevar Therapeutics, Acquires, Worldwide, Development, Commercialization, Rights, Oasmia, Apealea

17. Sorrento Signs an Exclusive License Agreement with Mabpharm for ACE-MAB to Treat COVID-19

Published: Mar 24, 2020 | Tags: Sorrento, Signs, Exclusive, License Agreement, Mabpharm,  ACE-MAB, COVID-19

18. Astellas Collaborates with CytomX Therapeutics to Develop Probody T-Cell Engaging Bispecific Therapies for Cancer Indications

Published: Mar 23, 2020 | Tags: Astellas, Collaborates, CytomX Therapeutics, Develop, Probody, T-Cell Engaging Bispecific Therapies, Cancer Indications

19. QIAGEN Releases QIAstat-Dx Test Kit as the First Syndromic Test to Detect COVID-19 Under New FDA Policy

Published: Mar 23, 2020 | Tags: QIAGEN, Releases, QIAstat-Dx Test Kit, First Syndromic Test, Detect, COVID-19, Under, New, FDA Policy

20. Genentech Receives the US FDA’s Approval for P-III Clinical Study Evaluating Actemra to Treat Hospitalized Patients with Severe COVID-19 Pneumonia

Published: Mar 23, 2020 | Tags:  Genentec, Receives, US, FDA, Approval, P-III, Clinical Study, Evaluating, Actemra, Treat, Hospitalized, Patients, Severe, COVID-19, Pneumonia

21. Sorrento and SmartPharm To Develop Novel Gene-Encoded Antibody Vaccine for COVID-19

Published: Mar 23, 2020 | Tags:  Sorrento, SmartPharm, Develop, Novel, Gene-Encoded, Antibody, Vaccine, COVID-19

22. Roche Highlights its Response to COVID-19 Pandemic

Published: Mar 24, 2020 | Tags: Roche, Highlights, Response, COVID-19, Pandemic

23. Amgen and its Foundation Grant $12.5M to Support COVID-19 Relief Efforts Globally

Published: Mar 23, 2020 | Tags: Amgen, Foundation, Grant, $12.5M, COVID-19, Relief Efforts, Globally

24. Takeda Collaborates with Codexis to Advance Novel Gene Therapies for Rare Genetic Disorders

Published: Mar 23, 2020 | Tags: Takeda, Collaborates, Codexis, Advance, Novel, Gene Therapies, Rare Genetic Disorders

25. Celltrion to Launch Rapid Self-Testing Kit and Accelerates the Development of Treatment Against COVID-19

Published: Mar 23, 2020 | Tags: Celltrion, Launch, Rapid Self-Testing Kit, Accelerates, Development, Treatment, Against, COVID-19

26. Sorrento Develops STI-4398 (COVIDTRAP Protein) to Prevent and Treat COVID-19

Published: Mar 20, 2020 | Tags: Sorrento, Develops, STI-4398, COVIDTRAP Protein, Prevent, Treat, COVID-19

27. Microsoft and Adaptive Biotechnologies Expand Their Collaboration for Mapping the Immune Response to COVID-19

Published: Mar 20, 2020 | Tags: Microsoft, Adaptive Biotechnologies, Expand, Collaboration, Mapping, Immune Response, COVID-19

28. Bayer Signs a Research and License Agreement with Curadev to Develop Novel STING Antagonists Across Multiple Indications

Published: Mar 23, 2020 | Tags: Bayer, Curadev, Signs, Research, License Agreement, Develop, Novel, STING Antagonists, Across, Multiple Indications

29. Takeda’s Entyvio (vedolizumab) Receives NMPA’s Approval to Treat Moderate to Severe Active Ulcerative Colitis and Crohn’s Disease

Published: Mar 23, 2020 | Tags: Takeda, Entyvio, vedolizumab, Receives, NMPA, Approval, Treat, Moderate, Severe, Active, Ulcerative Colitis, Crohn’s Disease

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post